Search

Author/Creator Pernas, Sònia

1. A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation. Issue 11 (November 2020)

Authors:
Prat, Aleix; Guarneri, Valentina; Paré, Laia; Griguolo, Gaia; Pascual, Tomás; Dieci, Maria V; Chic, Núria; González-Farré, Blanca; Frassoldati, Antonio; Sanfeliu, Esther; Cejalvo, Juan M; Muñoz, Montserrat; Bisagni, Giancarlo; Brasó-Maristany, Fara; Urso, Loredana; Vidal, Maria; Brandes, Alba A; ...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 11(2020)
Page Start:
1455
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. HER2-enriched subtype as a predictor of pathological complete response following trastuzumab and lapatinib without chemotherapy in early-stage HER2-positive breast cancer (PAMELA): an open-label, single-group, multicentre, phase 2 trial. Issue 4 (April 2017)

Authors:
Llombart-Cussac, Antonio; Cortés, Javier; Paré, Laia; Galván, Patricia; Bermejo, Begoña; Martínez, Noelia; Vidal, Maria; Pernas, Sònia; López, Rafael; Muñoz, Montserrat; Nuciforo, Paolo; Morales, Serafín; Oliveira, Mafalda; de la Peña, Lorena; Peláez, Alexandra; Prat, Aleix
Journal:
Lancet oncology
Issue:
Volume 18:Issue 4(2017:Apr.)
Page Start:
545
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search